EUVIMEDEUVIMED entdecken
Leserbrief

Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma

Thais Lizondo López, Iria Carro Méndez, Esther Carcelero San Martín

Medicina Clínica · 2024

DOI: 10.1016/j.medcli.2023.11.003 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Medicina Clínica, 2024. Verfasst von Thais Lizondo López und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Service, Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: tlizondo@clinic.cat. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Myocarditis, Liver Neoplasms, Myositis. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularMyocarditisLiver NeoplasmsMyositisAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedHumansAntineoplastic Combined Chemotherapy Protocols

Substanzen

tremelimumabdurvalumabAntibodies, MonoclonalAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Pharmacy Service, Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: tlizondo@clinic.cat.
  • Pharmacy Service, Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain.

Zitieren

APA

Lizondo López, T., Carro Méndez, I., & Carcelero San Martín, E. (2024). Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma. Medicina Clínica. https://doi.org/10.1016/j.medcli.2023.11.003

Vancouver

Lizondo López T, Carro Méndez I, Carcelero San Martín E. Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma. Medicina Clínica. 2024. doi:10.1016/j.medcli.2023.11.003

BibTeX
@article{LizondoLpez2024,
  author = {Lizondo López, Thais and Carro Méndez, Iria and Carcelero San Martín, Esther},
  title = {Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma},
  journal = {Medicina Clínica},
  year = {2024},
  doi = {10.1016/j.medcli.2023.11.003}
}
Kostenlos starten →